However, the ability of EA to reduce hepatic lipid accumulation, ameliorate the resulted dyslipidemia, and the increment in the levels of ALT and AST with the previously discussed ameliorative effect on liver fibrosis was the clearest evidence that EA could prevent NAFLD in T1DM-induced rats. The gene discussed is GPT; the disease is type 1 diabetes mellitus.